Author Question: How often can a patient transfer from one PCP provider to another? a. Once a year b. Twice a ... (Read 29 times)

dalyningkenk

  • Hero Member
  • *****
  • Posts: 598
How often can a patient transfer from one PCP provider to another?
 
  a. Once a year
  b. Twice a year
  c. One time only
  d. As often desired

Question 2

If an MCP notices a pattern of grievances related to the performance of a provider, it may:
 
  a. counsel the provider.
  b. terminate the contract with the provider.
  c. stop referrals to the provider.
  d. turn the provider over to the licensing commission.



wuly

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

Answer: d

Answer to Question 2

Answer: b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library